We were very pleased with our choice to engage innoVitro’s contractility service. The studies using human iPSC-derived cardiomyocytes were tailored to our needs to provide results comparable to already existing (in house) data and the fast execution followed by a comprehensive study report completed the service perfectly.
- innoVation Series – Research Article of the Month – July 2021July’s innovation Series article by Luo and Li et al., 2020 focuses on the role of type 2 […]
- innoVation Series – Research Article of the Month – June 2021Similar to April’s innovation series issue, we have chosen an article that deals with the […]
- 11th World Congress on Alternatives and Animal Use in Life Sciences 23rd of August – 2nd of September, 2021Meet us at the 11th World Congress on Alternatives and Animal use in Life Sciences this year. […]